In addition to being the Dean of the College of Business Administration at San Diego State University since August 2002, Dr. Naughton founded Histogen, Inc. in 2007, and currently serves as Chief Executive Officer and Chairman of the Board for the Company. She has spent more than 15 years extensively researching the tissue engineering process, holds more than 90 U.S. and foreign patents and has been extensively published in the field. firstname.lastname@example.org
David Nassif, President and CFO
David W. Nassif, J.D. was appointed President and CFO in May 2011. Previously, he was a principal at Strategic Consulting Services, providing high-level management consulting to life sciences companies, including Histogen. He served as the Executive Vice President, Chief Financial Officer, Secretary and Treasurer of Zogenix, Inc. from May 2007 to March 2010 after consulting for Zogenix from October 2006 to May 2007. From May 2006 to October 2006, as well as earlier from 2001 to 2002, Previously, Mr. Nassif served as a principal at Strategic Consulting Services providing capital raising, mergers and acquisitions, licensing and investor relations services to various public and private life science and technology companies.
Jonathan N. Mansbridge, M.A., Ph.D., Chief Scientific Officer
Jonathan Mansbridge won an Open Scholarship to Trinity College, Cambridge in 1957 and a Senior Scholarship in 1960. He received a double first honours degree in Natural Sciences from Cambridge University in 1961, a PhD in biochemistry in 1964 and an MA in 1965. He was on the faculty at the Biochemistry Department of the University of Queensland from 1965-1981, with sabbaticals at the Beatson Institute, Glasgow (1970) and Stanford (1980).
Mark Baumgartner, Director of Engineering
Mr. Baumgartner joined the company in 2007 with more than 20 years experience in product and process development for regulated biologic products. During 2006 and 2007 Mr. Baumgartner worked as a consultant to the biomedical and biopharmaceutical sectors on several projects for product development and process engineering. Mr. Baumgartner worked as Director of Process Development for Smith-Nephew Wound Management LLC, producing biological medical device products from 2002 to 2006. email@example.com
Dr. Mark A. Hubka, Director of Clinical Affairs
Dr. Hubka brings more than 25 years of clinical experience from the fields of orthopedics and sports medicine to Histogen. His experience in managed care includes his time as State Director of the largest designated provider network (DPN) in California, focused on worker's compensation. firstname.lastname@example.org
Eileen Naughton Brandt, Director of Corporate Communications
Eileen brings more than 5 years of experience in communications and public relations to Histogen. Prior to joining Histogen in 2007, she held positions with Moore Media Relations, Inc., a firm working with high-technology companies throughout the U.S. on various PR projects, with a focus on media relations. Previously, Eileen held positions at San Diego State University's Entrepreneurial Management Center, beginning as a Student Assistant at the San Diego State University and later serving as Program Coordinator. email@example.com
Emmett Pinney B.S., M.S., Director of Oncology & Special Projects
In addition to degrees in Microbiology and Bioengineering, Emmett brings 35 years of laboratory experience to Histogen, including 10 years in Research & Development for Advanced Tissue Sciences where he was instrumental in developing some of their most successful products as well as supervising the internship program. Emmett holds 6 domestic and international patents, and has authored 25 peer reviewed articles. He was also the Co-Founder and CSO of a small profitable biotech company, Intella, L.L.C. firstname.lastname@example.org
Michael P. Zimber, Ph.D., Director of Applied Research
Dr. Michael Zimber brings to Histogen over 15 years of diverse experience in the biotechnology and pharmaceutical industry with a multi-disciplinary background in early phase discovery, preclinical development and translational phases of therapeutic development. He began his scientific career studying developmental biology conducting research on tissue pattern formation and amphibian limb regeneration. email@example.com